Published in Artif Organs on September 01, 2010
Preliminary study on the development of a system dynamics model: the case of EVAHEART. J Artif Organs (2013) 0.76
Long-term durability test of axial-flow ventricular assist device under pulsatile flow. J Artif Organs (2016) 0.76
Clinical spectrum of mediastinal cysts. Chest (2003) 3.69
B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol (2006) 3.37
The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer (2002) 3.29
Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis. Circulation (2004) 3.16
Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res (2002) 3.10
Effectiveness of bystander-initiated cardiac-only resuscitation for patients with out-of-hospital cardiac arrest. Circulation (2007) 3.01
Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans. Circulation (2006) 2.81
Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma. Ann Thorac Surg (2004) 2.38
Third-generation blood pumps with mechanical noncontact magnetic bearings. Artif Organs (2006) 2.35
Primary germ cell tumors in the mediastinum: a 50-year experience at a single Japanese institution. Cancer (2003) 2.27
Toward quality improvement of thoracic aortic surgery: estimating volume-outcome effect from nationwide survey. Eur J Cardiothorac Surg (2009) 2.15
Effect of procedural volume on outcome of coronary artery bypass graft surgery in Japan: implication toward public reporting and minimal volume standards. J Thorac Cardiovasc Surg (2008) 2.13
Mid-term results and costs of coronary artery bypass vs drug-eluting stents for unprotected left main coronary artery disease. Circ J (2010) 2.08
Age-specific risk stratification in 13488 isolated coronary artery bypass grafting procedures. Interact Cardiovasc Thorac Surg (2011) 2.05
Hepatocyte growth factor stimulates proliferation of respiratory epithelial cells during postpneumonectomy compensatory lung growth in mice. Am J Respir Cell Mol Biol (2002) 1.91
Age and preoperative total bilirubin level can stratify prognosis after extracorporeal pulsatile left ventricular assist device implantation. Circ J (2010) 1.91
EVAHEART: an implantable centrifugal blood pump for long-term circulatory support. Jpn J Thorac Cardiovasc Surg (2002) 1.90
14-3-3 Interacts directly with and negatively regulates pro-apoptotic Bax. J Biol Chem (2002) 1.84
Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets. J Thorac Cardiovasc Surg (2005) 1.82
Homozygosity haplotype allows a genomewide search for the autosomal segments shared among patients. Am J Hum Genet (2007) 1.76
Surgical resection for lung cancer with infiltration of the thoracic aorta. J Thorac Cardiovasc Surg (2005) 1.75
Surgical management of aortic regurgitation associated with takayasu arteritis and other forms of aortitis. Ann Thorac Surg (2007) 1.69
Endogenous bone-marrow-derived stem cells contribute only a small proportion of regenerated myocardium in the acute infarction model. J Heart Lung Transplant (2005) 1.60
Novel risk scoring system with preoperative objective parameters gives a good prediction of 1-year mortality in patients with a left ventricular assist device. Circ J (2012) 1.56
Aortic insufficiency in patients with sustained left ventricular systolic dysfunction after axial flow assist device implantation. Circ J (2014) 1.51
Preoperative levels of bilirubin or creatinine adjusted by age can predict their reversibility after implantation of left ventricular assist device. Circ J (2012) 1.51
Efficacy and safety of tracheobronchoplasty after induction therapy for locally advanced lung cancer. J Thorac Cardiovasc Surg (2003) 1.51
Management of patients with intramural hematoma involving the ascending aorta. J Thorac Cardiovasc Surg (2002) 1.50
Low cardiac output stimulates vasopressin release in patients with stage d heart failure. Circ J (2014) 1.50
Biocompatible inkjet printing technique for designed seeding of individual living cells. Tissue Eng (2006) 1.50
Microcirculation of the bulbar conjunctiva in the goat implanted with a total artificial heart: effects of pulsatile and nonpulsatile flow. ASAIO J (2004) 1.48
Fibronectin-hepatocyte growth factor enhances reendothelialization in tissue-engineered heart valve. Ann Thorac Surg (2005) 1.46
Novel tissue-engineered biodegradable material for reconstruction of vascular wall. Ann Thorac Surg (2005) 1.46
Combination evaluation of preoperative risk indices predicts requirement of biventricular assist device. Circ J (2012) 1.46
Virtual mediastinoscopy for safer and more accurate mediastinal exploration. Ann Thorac Surg (2007) 1.44
Report from J-PULSE multicenter registry of patients with shock-resistant out-of-hospital cardiac arrest treated with nifekalant hydrochloride. Circ J (2010) 1.44
Clinicopathological investigation of 20 cases of primary tracheal cancer. Eur J Cardiothorac Surg (2003) 1.44
Effects of voglibose and nateglinide on glycemic status and coronary atherosclerosis in early-stage diabetic patients. Circ J (2012) 1.44
Prevalence and optimal management strategy for aortic regurgitation in tetralogy of Fallot. Eur J Cardiothorac Surg (2004) 1.43
In vitro fabrication of functional three-dimensional tissues with perfusable blood vessels. Nat Commun (2013) 1.41
Mechanical circulatory support devices (MCSD) in Japan: current status and future directions. J Artif Organs (2005) 1.41
Enhanced perigraft angiogenesis prevents prosthetic graft infection. Ann Thorac Surg (2008) 1.40
Novel scoring system using postoperative cardiopulmonary exercise testing predicts future explantation of left ventricular assist device. Circ J (2014) 1.40
Serial changes in renal function as a prognostic indicator in advanced heart failure patients with left ventricular assist system. Ann Thorac Surg (2012) 1.39
Is extracorporeal life support contraindicated in elderly patients? Ann Thorac Surg (2007) 1.38
In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells. Exp Cell Res (2003) 1.37
Hemodynamic and echocardiographic evaluation of orthotopic heart transplantation with the modified bicaval anastomosis technique. Circ J (2009) 1.37
Fabrication of functional three-dimensional tissues by stacking cell sheets in vitro. Nat Protoc (2012) 1.37
Optimal distance of malignant negative margin in excision of nonsmall cell lung cancer: a multicenter prospective study. Ann Thorac Surg (2004) 1.33
Who would be a candidate for bridge to recovery during prolonged mechanical left ventricular support in idiopathic dilated cardiomyopathy? J Thorac Cardiovasc Surg (2005) 1.33
Retracted Ventricular afterload and ventricular work in fontan circulation: comparison with normal two-ventricle circulation and single-ventricle circulation with blalock-taussig shunts. Circulation (2002) 1.32
Tissue cardiomyoplasty using bioengineered contractile cardiomyocyte sheets to repair damaged myocardium: their integration with recipient myocardium. Transplantation (2005) 1.30
Up to 151 days of continuous animal perfusion with trivial heparin infusion by the application of a long-term durable antithrombogenic coating to a combination of a seal-less centrifugal pump and a diffusion membrane oxygenator. J Artif Organs (2007) 1.29
FGF-2 suppresses cellular senescence of human mesenchymal stem cells by down-regulation of TGF-beta2. Biochem Biophys Res Commun (2007) 1.28
Late aortic insufficiency related to poor prognosis during left ventricular assist device support. Ann Thorac Surg (2011) 1.26
Longer preservation of cardiac performance by sheet-shaped myoblast implantation in dilated cardiomyopathic hamsters. Cardiovasc Res (2006) 1.19
Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension (2004) 1.19
Higher susceptibility of NOG mice to xenotransplanted tumors. J Toxicol Sci (2009) 1.19
Left ventricular mechanical support with Impella provides more ventricular unloading in heart failure than extracorporeal membrane oxygenation. ASAIO J (2011) 1.19
Grafted skeletal myoblast sheets attenuate myocardial remodeling in pacing-induced canine heart failure model. J Thorac Cardiovasc Surg (2006) 1.17
At least thirty-four days of animal continuous perfusion by a newly developed extracorporeal membrane oxygenation system without systemic anticoagulants. Artif Organs (2002) 1.16
FGF-2 increases osteogenic and chondrogenic differentiation potentials of human mesenchymal stem cells by inactivation of TGF-beta signaling. Cytotechnology (2007) 1.15
Heat shock protein 72 enhances manganese superoxide dismutase activity during myocardial ischemia-reperfusion injury, associated with mitochondrial protection and apoptosis reduction. Circulation (2002) 1.15
Dai-kenchu-to, a Chinese herbal medicine, improves stasis of patients with total gastrectomy and jejunal pouch interposition. Am J Surg (2006) 1.15
Intrathoracic neurogenic tumors--50 years' experience in a Japanese institution. Eur J Cardiothorac Surg (2004) 1.14
Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis. Cancer Res (2004) 1.14
The results of total arch graft implantation with open stent-graft placement for type A aortic dissection. J Thorac Cardiovasc Surg (2002) 1.12
Isolation and characterization of vasohibin-2 as a homologue of VEGF-inducible endothelium-derived angiogenesis inhibitor vasohibin. Arterioscler Thromb Vasc Biol (2006) 1.11
The L-cysteine/L-cystine shuttle system provides reducing equivalents to the periplasm in Escherichia coli. J Biol Chem (2010) 1.10
Electrically communicating three-dimensional cardiac tissue mimic fabricated by layered cultured cardiomyocyte sheets. J Biomed Mater Res (2002) 1.10
Myocardial regeneration therapy for heart failure: hepatocyte growth factor enhances the effect of cellular cardiomyoplasty. Circulation (2002) 1.10
Greatwall kinase and cyclin B-Cdk1 are both critical constituents of M-phase-promoting factor. Nat Commun (2012) 1.10
Hepatic dysfunction after left ventricular mechanical assist in patients with end-stage heart failure: role of inflammatory response and hepatic microcirculation. Ann Thorac Surg (2002) 1.10
The use of patterned dual thermoresponsive surfaces for the collective recovery as co-cultured cell sheets. Biomaterials (2005) 1.09
In vitro engineering of vascularized tissue surrogates. Sci Rep (2013) 1.08
Clinical spectrum of primary mediastinal tumors: a comparison of adult and pediatric populations at a single Japanese institution. J Surg Oncol (2003) 1.08
Pulsatile control of rotary blood pump and cardiac workload. J Thorac Cardiovasc Surg (2013) 1.08
Cardiac rest and reserve function in patients with Fontan circulation. J Am Coll Cardiol (2006) 1.08
Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts. Am J Physiol Heart Circ Physiol (2005) 1.06
Amelioration of pulmonary emphysema by in vivo gene transfection with hepatocyte growth factor in rats. Circulation (2005) 1.06
Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation. Eur Heart J (2005) 1.06
Retracted Arterial hemodynamics in patients after Kawasaki disease. Circulation (2005) 1.06
Multidetector CT of high-risk patients with occult gastrointestinal stromal tumors. AJR Am J Roentgenol (2003) 1.05
Bioengineered three-layered robust and elastic artery using hemodynamically-equivalent pulsatile bioreactor. Circulation (2008) 1.05
Effects of mechanical valve orifice direction on the flow pattern in a ventricular assist device. J Artif Organs (2007) 1.05
High-dose carvedilol therapy for mechanical circulatory assisted patients. J Artif Organs (2010) 1.04
Hepatocyte growth factor suppresses vascular medial hyperplasia and matrix accumulation in advanced pulmonary hypertension of rats. Circulation (2004) 1.04
Unusual type of left paraduodenal hernia caused by a separated peritoneal membrane. J Gastroenterol (2002) 1.04
The helical flow pump with a hydrodynamic levitation impeller. J Artif Organs (2012) 1.04
Risk factors for post-transplant low output syndrome. Eur J Cardiothorac Surg (2012) 1.03
Early clinical outcomes of new pediatric extracorporeal life support system (Endumo (2000) in neonates and infants. J Artif Organs (2013) 1.03
Laparoscopic intragastric resection of gastric stromal tumor located at the esophago-cardiac junction. Surg Laparosc Endosc Percutan Tech (2004) 1.01
Therapeutic effects of a new lymphocyte homing reagent FTY720 in interleukin-10 gene-deficient mice with colitis. Inflamm Bowel Dis (2004) 1.01
Matured mediastinal teratoma extending into the cervical neck of an adult. Interact Cardiovasc Thorac Surg (2003) 1.01
Development of a novel drive mode to prevent aortic insufficiency during continuous-flow LVAD support by synchronizing rotational speed with heartbeat. J Artif Organs (2013) 1.01
G-CSF promotes bone marrow cells to migrate into infarcted mice heart, and differentiate into cardiomyocytes. Cell Transplant (2004) 1.01
Vacuum-assisted closure with Safetac technology for mediastinitis in patients with a ventricular assist device. J Artif Organs (2010) 1.01